Showing results (121-130 of 6,758) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|March 24, 2012
Relationship between bitter-taste receptor genotype and solid medication formulation usage among young children: a retrospective analysisSarah V Lipchock, Danielle R Reed, Julie A MennellaClinical Therapeutics|March 27, 2012
Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptorIris Navarro-Millán, Jasvinder A Singh, Jeffrey R CurtisClinical Therapeutics|March 27, 2012
Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid programKenneth A Lawson, Michael Johnsrud, Paul Hodgkins, et al.Clinical Therapeutics|March 27, 2012
An assessment of the association between carvedilol exposure and severe hypersensitivity reactions, angioedema, and anaphylactic reactions: a retrospective nested case-control analysisCarol E Koro, Margaret D Sowell, Monika StenderClinical Therapeutics|January 31, 2012
Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database studyMachaon M K Bonafede, Kathleen M Fox, Barbara H Johnson, et al.Clinical Therapeutics|January 31, 2012
Tolerability and pharmacokinetics of a new P-glycoprotein inhibitor, HM30181, in healthy Korean male volunteers: single- and multiple-dose randomized, placebo-controlled studiesTae-Eun Kim, Namyi Gu, Seo Hyun Yoon, et al.Clinical Therapeutics|January 31, 2012
Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP DatabaseEnnie L Cano, Nadia Z Haque, Verna L Welch, et al.Clinical Therapeutics|January 31, 2012
Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosisNawab Qizilbash, Ignacio Mendez, Rainel Sanchez-de la RosaClinical Therapeutics|January 31, 2012
Comparing health outcomes and costs of general vaccination with pneumococcal conjugate vaccines in Sweden: a Markov modelAsa By, Patrik Sobocki, Arne Forsgren, et al.Clinical Therapeutics|March 31, 2012
Economic evaluation of sequential treatments for follicular non-hodgkin lymphomaErkki J Soini, Janne A Martikainen, Ville Vihervaara, et al.Pageof 676